No results for ‘’
RPG Life Sciences Ltd
NSE: RPGLIFE BSE: 532983
₹2300.20
(0.01%)
Wed, 27 May 2026, 05:43 pm
Market Cap37.98B
PE Ratio33.03
Dividend0.87
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2009
- Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009.
2010
- Mr. Ajit Singh Chouhan has been appointed as Managing Director of the Company
- Mr. Sachin Raole has been designated as Chief Financial Officer (CFO) of the Company.
2011
- RPG Life Sciences launches dialysis deferring drug
- Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company.
2012
- Board has recommended an equity dividend of Rs. 0.80 per share (10%).
2013
- RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility
- RPG Life Sciences bagged 'Asia's Best Employer Brand Awards 2013' in Singapore.
2014
- Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014.
2015
- RPG Life Plans Skincare Foray
2016
- RPG Life Sciences announces foray into Cosmetic Industry
- RPG Life Sciences to expand its formulations business
- RPG Life gains over 14 percent on getting EUGMP certification
2019
- RPG Life Sciences enters Anti-Diabetic therapeutic area.